MIGUEL A PERALES
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology NEW YORK, NY NPI 1922079839
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology NY Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$698,686.03
- Category: General Payments
- Program years: PY2018–2024
- Record count: 358
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $95,009.22 across 37 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $62,974.00 | 11 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,741.00 | 3 |
| Travel and Lodging | $14,943.42 | 12 |
| Food and Beverage | $1,350.80 | 11 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $34,340.98 | 18 |
| SANOFI-AVENTIS U.S. LLC | $30,631.89 | 5 |
| Merck Sharp & Dohme Corporation | $10,370.00 | 2 |
| E.R. Squibb & Sons, L.L.C. | $5,730.00 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $4,350.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $3,200.00 | 1 |
| Novartis Pharma AG | $2,042.61 | 2 |
| CSL Behring | $1,950.00 | 1 |
| BioNTech SE | $1,050.00 | 1 |
| National Marrow Donor Program | $986.44 | 2 |
| Pierre Fabre Pharmaceuticals, Inc. | $210.90 | 1 |
| Kite Pharma, Inc. | $146.40 | 1 |
By program year
Records — PY2024 (37)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.